SBRT Well Tolerated, Effective for Primary Lung Neuroendocrine Tumor
Cancer Therapy Advisor,
(HealthDay News) — For patients with primary lung neuroendocrine tumor (LNET), stereotactic body radiotherapy (SBRT) is well…
(HealthDay News) — For patients with primary lung neuroendocrine tumor (LNET), stereotactic body radiotherapy (SBRT) is well…
THURSDAY, Feb. 23, 2023 (HealthDay News) — For patients with primary lung neuroendocrine tumor (LNET), stereotactic body…
THURSDAY, Feb. 23, 2023 (HealthDay News) -- For patients with primary lung neuroendocrine tumor (LNET), stereotactic body…
THURSDAY, Feb. 23, 2023 (HealthDay News) -- For patients with primary lung neuroendocrine tumor (LNET), stereotactic body…